Wadie W, Mohamed A, Masoud M, Rizk H, Sayed H
Naunyn Schmiedebergs Arch Pharmacol. 2020; 394(3):447-455.
PMID: 33034714
DOI: 10.1007/s00210-020-01980-5.
Kim M, Kang Y, Kwon M, Choi Y, Choi M, Chi H
Int J Mol Sci. 2018; 19(4).
PMID: 29642532
PMC: 5979538.
DOI: 10.3390/ijms19041120.
Ruiz M, Rigalli J, Arias A, Villanueva S, Banchio C, Vore M
Drug Metab Dispos. 2012; 41(2):275-80.
PMID: 23077105
PMC: 3558861.
DOI: 10.1124/dmd.112.047357.
Savander M, Ropponen A, Avela K, Weerasekera N, Cormand B, Hirvioja M
Gut. 2003; 52(7):1025-9.
PMID: 12801961
PMC: 1773695.
DOI: 10.1136/gut.52.7.1025.
Gartung C, Matern S
Yale J Biol Med. 1997; 70(4):355-63.
PMID: 9626756
PMC: 2589349.
Phase III elimination: another two-edge sword.
Vore M
Environ Health Perspect. 1994; 102(5):422-3.
PMID: 8593834
PMC: 1567152.
DOI: 10.1289/ehp.94102422.
Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver.
BOSSARD R, Stieger B, ONeill B, Fricker G, Meier P
J Clin Invest. 1993; 91(6):2714-20.
PMID: 8514879
PMC: 443336.
DOI: 10.1172/JCI116511.
S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.
Friedel H, Goa K, Benfield P
Drugs. 1989; 38(3):389-416.
PMID: 2680435
DOI: 10.2165/00003495-198938030-00004.
Oestradiol 17 beta-glucuronide increases tight-junctional permeability in rat liver.
Kan K, Monte M, Parslow R, Coleman R
Biochem J. 1989; 261(1):297-300.
PMID: 2637685
PMC: 1138818.
DOI: 10.1042/bj2610297.
Oestradiol 17 beta-glucuronide and tight junctional permeability increase.
Coleman R, Kan K
Biochem J. 1990; 266(2):622.
PMID: 2317210
PMC: 1131180.
The pathophysiological significance of increased tight-junctional permeability during oestrogen cholestasis.
Jaeschke H
Biochem J. 1990; 266(2):620-2.
PMID: 2317209
PMC: 1131179.
Cellular mechanisms of intrahepatic cholestasis.
Drugs. 1990; 40 Suppl 3:84-97.
PMID: 2081484
DOI: 10.2165/00003495-199000403-00009.
Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis.
Almasio P, Bortolini M, Pagliaro L, Coltorti M
Drugs. 1990; 40 Suppl 3:111-23.
PMID: 2081476
DOI: 10.2165/00003495-199000403-00011.
The role of SAMe in the treatment of liver disease.
Williams R, Lieber C
Drugs. 1990; 40 Suppl 3:1-2.
PMID: 2081475
DOI: 10.2165/00003495-199000403-00002.
Pathophysiology and clinical basis of prevention and treatment of complications of chronic liver disease.
Wagner S, Lautz H, Muller M, Schmidt F
Klin Wochenschr. 1991; 69(3):112-20.
PMID: 2013971
DOI: 10.1007/BF01795954.
